TWC
EDIT icon

TD Waterhouse Canada’s Editas Medicine EDIT Stock Holding History

TD Waterhouse Canada’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656 Hold
200
– – ﹤0.01% 2226
2026
Q1 		$520 Hold
200
– – ﹤0.01% 2148
2025
Q4 		$410 Sell
200
-300
-60% -$866 ﹤0.01% 1916
2025
Q3 		$1.77K Hold
500
– – ﹤0.01% 1846
2025
Q2 		$1.12K Hold
500
– – ﹤0.01% 1798
2025
Q1 		$565 Hold
500
– – ﹤0.01% 1788
2024
Q4 		$635 Sell
500
-329
-40% -$838 ﹤0.01% 1810
2024
Q3 		$2.71K Hold
829
– – ﹤0.01% 1593
2024
Q2 		$3.84K Sell
829
-800
-49% -$4.51K ﹤0.01% 1541
2024
Q1 		$13.9K Hold
1,629
– – ﹤0.01% 1306
2023
Q4 		$19.1K Hold
1,629
– – ﹤0.01% 1131
2023
Q3 		$14.6K Hold
1,629
– – ﹤0.01% 1151
2023
Q2 		$16.4K Sell
1,629
-70
-4% -$610 ﹤0.01% 1151
2023
Q1 		$14.8K Hold
1,699
– – ﹤0.01% 1149
2022
Q4 		$17.8K Sell
1,699
-150
-8% -$1.65K ﹤0.01% 1117
2022
Q3 		$27.9K Buy
1,849
+650
+54% +$10.1K ﹤0.01% 1023
2022
Q2 		$17.4K Hold
1,199
– – ﹤0.01% 1141
2022
Q1 		$27.4K Hold
1,199
– – ﹤0.01% 1109
2021
Q4 		$36.1K Buy
+1,199
New +$41.3K ﹤0.01% 1074

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

TD Waterhouse Canada's EDIT Position: Q2 2026 in Review

TD Waterhouse Canada held its Editas Medicine (EDIT) position steady in Q2 2026 at 200 shares worth $656. The position accounts for ﹤0.01% of the portfolio, ranked #2226.

TD Waterhouse Canada first reported a position in EDIT in Q4 2021 and has held it in 19 quarters since. The position peaked at $36.1K in Q4 2021. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • TD Waterhouse Canada held 200 shares of Editas Medicine worth $656 as of Q2 2026.
  • TD Waterhouse Canada left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2226 holding.
  • TD Waterhouse Canada first reported a position in Editas Medicine in Q4 2021 and has held it in 19 quarters since.
  • TD Waterhouse Canada's Editas Medicine position peaked at $36.1K in Q4 2021.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.